Design Therapeutics (DSGN) Gets a Hold from RBC Capital
RBC Capital analyst Leonid Timashev maintained a Hold rating on Design Therapeutics (DSGN – Research Report) today and set a price target of ...
Carmell Therapeutics rebrands to Longevity Health Holdings
Carmell announced a comprehensive corporate rebranding initiative aimed at better aligning the Company’s market and investor facing image with ...
News-Medical.Net4d
Insilico Medicine's AI-driven drug Rentosertib receives official generic name
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...
FY2025 EPS Estimates for JSPR Boosted by Cantor Fitzgerald
Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on ...
New version of Merck's Keytruda faces possible patent battle, WSJ reports
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...